European Vaccine Initiative

This study tests a new malaria vaccine called SUM-101 in 69 healthy children aged 5 months to 5 years in Burkina Faso. The goal is to see if the vaccine is safe and triggers a strong immune response. Researchers will compare different doses to find the best one for future use.